139 related articles for article (PubMed ID: 8226946)
1. Study of the conformation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by fluorescence spectroscopy.
Neyroz P; Desdouits F; Benfenati F; Knutson JR; Greengard P; Girault JA
J Biol Chem; 1993 Nov; 268(32):24022-31. PubMed ID: 8226946
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.
Girault JA; Hemmings HC; Williams KR; Nairn AC; Greengard P
J Biol Chem; 1989 Dec; 264(36):21748-59. PubMed ID: 2557337
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo.
Desdouits F; Cohen D; Nairn AC; Greengard P; Girault JA
J Biol Chem; 1995 Apr; 270(15):8772-8. PubMed ID: 7721783
[TBL] [Abstract][Full Text] [Related]
4. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.
Desdouits F; Siciliano JC; Greengard P; Girault JA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2682-5. PubMed ID: 7708705
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra.
Tsou K; Snyder GL; Greengard P
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3462-5. PubMed ID: 8386374
[TBL] [Abstract][Full Text] [Related]
6. DARPP-32: an integrator of neurotransmission.
Svenningsson P; Nishi A; Fisone G; Girault JA; Nairn AC; Greengard P
Annu Rev Pharmacol Toxicol; 2004; 44():269-96. PubMed ID: 14744247
[TBL] [Abstract][Full Text] [Related]
7. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.
Hemmings HC; Nairn AC; Greengard P
J Biol Chem; 1984 Dec; 259(23):14491-7. PubMed ID: 6501303
[TBL] [Abstract][Full Text] [Related]
8. The role of DARPP-32 in the actions of drugs of abuse.
Nairn AC; Svenningsson P; Nishi A; Fisone G; Girault JA; Greengard P
Neuropharmacology; 2004; 47 Suppl 1():14-23. PubMed ID: 15464122
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
Bibb JA; Snyder GL; Nishi A; Yan Z; Meijer L; Fienberg AA; Tsai LH; Kwon YT; Girault JA; Czernik AJ; Huganir RL; Hemmings HC; Nairn AC; Greengard P
Nature; 1999 Dec; 402(6762):669-71. PubMed ID: 10604473
[TBL] [Abstract][Full Text] [Related]
10. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.
Svenningsson P; Lindskog M; Rognoni F; Fredholm BB; Greengard P; Fisone G
Neuroscience; 1998 May; 84(1):223-8. PubMed ID: 9522376
[TBL] [Abstract][Full Text] [Related]
11. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.
Håkansson K; Lindskog M; Pozzi L; Usiello A; Fisone G
Parkinsonism Relat Disord; 2004 Jul; 10(5):281-6. PubMed ID: 15196506
[TBL] [Abstract][Full Text] [Related]
12. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
[TBL] [Abstract][Full Text] [Related]
13. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.
Hemmings HC; Greengard P; Tung HY; Cohen P
Nature; 1984 Aug 9-15; 310(5977):503-5. PubMed ID: 6087160
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors.
Matsuyama S; Higashi H; Maeda H; Greengard P; Nishi A
J Neurochem; 2002 Apr; 81(2):325-34. PubMed ID: 12064480
[TBL] [Abstract][Full Text] [Related]
15. Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.
Hemmings HC; Nairn AC; Elliott JI; Greengard P
J Biol Chem; 1990 Nov; 265(33):20369-76. PubMed ID: 2173704
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine.
Snyder GL; Girault JA; Chen JY; Czernik AJ; Kebabian JW; Nathanson JA; Greengard P
J Neurosci; 1992 Aug; 12(8):3071-83. PubMed ID: 1494946
[TBL] [Abstract][Full Text] [Related]
17. Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents.
Qian Y; Forssberg H; Diaz Heijtz R
PLoS One; 2015; 10(10):e0140974. PubMed ID: 26488498
[TBL] [Abstract][Full Text] [Related]
18. The phosphorylation state of DARPP-32, a third messenger for dopamine, is regulated by in vivo pharmacological treatments.
Di Luca M; Cimino M; Cattabeni F
Neurochem Int; 1992 Mar; 20 Suppl():165S-170S. PubMed ID: 1365418
[TBL] [Abstract][Full Text] [Related]
19. Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.
Desdouits F; Siciliano JC; Nairn AC; Greengard P; Girault JA
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):211-6. PubMed ID: 9461512
[TBL] [Abstract][Full Text] [Related]
20. DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor-1.
Williams KR; Hemmings HC; LoPresti MB; Konigsberg WH; Greengard P
J Biol Chem; 1986 Feb; 261(4):1890-903. PubMed ID: 3511054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
